Skip to content

The effect of micro-focused ultrasound treatment on intradermal botulinum toxin type A injection

The effect of micro-focused ultrasound treatment on intradermal botulinum toxin type A injection

Status
Active, not recruiting
Phases
Phase 3
Study type
Interventional
Source
TCTR
Registry ID
TCTR20211029004
Enrollment
15
Registered
2021-10-29
Start date
2021-05-20
Completion date
Unknown
Last updated
2026-08-03

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Forehead hyperhidrosis Hyperhidrosis

Interventions

Intradermal botulinum toxin A injection,Microfocused ultrasound transducer 1.5 mm energy 0.18 Jcm2 Immediate Day 0 after Intradermal botulinum toxin A injection ,Microfocused ultrasound transducer 1.5
No Intervention No treatment,Experimental Procedure/Surgery,Experimental Procedure/Surgery,Experimental Procedure/Surgery
No Microfocused ultrasound treatment,Microfocused ultrasound day 0,Microfocused ultrasound day 7,Microfocused ultrasound day 14

Sponsors

Division of Dermatology, Department of Medicine, Faculty of Medicine Ramathibodi Hospital, Mahidol University
Lead Sponsor

Eligibility

Sex/Gender
All
Age
18 Years to No maximum

Inclusion criteria

Inclusion criteria: 1.Patients with homogeneous forehead hyperhidrosis, tested with iodine starch test 2.Age more than 18 year-old 3.No serious underlying diseases 4.Informed consent 5.Compatible with follow-up schedule

Exclusion criteria

Exclusion criteria: 1. Have concurrent skin conditions on forehead 2. History of skin cancer, uncontrolled acne vulgaris 3. History of surgery in the area within 6 months 4. History of botulinum toxin A injection on forehead within 6 months 5. History of filler injection on forehead within 1 year 6. Pregnancy or lactation 7. Withdraw

Design outcomes

Primary

MeasureTime frame
Area of anhidrosis area Day 28 after botulinum toxin in Iodine starch test

Secondary

MeasureTime frame
Adverse reactions Every visit (day 0, 7, 14, 28 after botulinum toxin A injection) Evaluated from patients and attending dermatologists

Countries

Thailand

Contacts

Public ContactSarawin Harnchoowong

Ramathibodi hospital

hsarawin@gmail.com662011211

Outcome results

None listed

Source: TCTR (via WHO ICTRP) · Data processed: Aug 9, 2026